BR0214606A - Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal - Google Patents

Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal

Info

Publication number
BR0214606A
BR0214606A BR0214606-1A BR0214606A BR0214606A BR 0214606 A BR0214606 A BR 0214606A BR 0214606 A BR0214606 A BR 0214606A BR 0214606 A BR0214606 A BR 0214606A
Authority
BR
Brazil
Prior art keywords
processes
preparation
cell growth
abnormal cell
treatment
Prior art date
Application number
BR0214606-1A
Other languages
English (en)
Inventor
David Harold Brown Ripin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0214606A publication Critical patent/BR0214606A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"PROCESSOS PARA A PREPARAçãO DE DERIVADOS BICìCLICOS SUBSTITUìDOS PARA O TRATAMENTO DE CRESCIMENTO DE CéLULA ANORMAL". A invenção refere-se a processos para a preparação de compostos da fórmula 1 e aos seus sais, solvatos e pró-drogas farmaceuticamente aceitáveis, em que R^ 1^, R^ 3^, R^ 4^, R^ 5^, R^ 11^, m e p são conforme aqui definidos. Os compostos de fórmula 1 são úteis no tratamento do crescimento de célula anormal em mamíferos pela administração de composições farmacêuticas.
BR0214606-1A 2001-11-30 2002-10-03 Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal BR0214606A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33464701P 2001-11-30 2001-11-30
PCT/IB2002/004097 WO2003045939A1 (en) 2001-11-30 2002-10-03 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth

Publications (1)

Publication Number Publication Date
BR0214606A true BR0214606A (pt) 2004-09-14

Family

ID=23308141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214606-1A BR0214606A (pt) 2001-11-30 2002-10-03 Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal

Country Status (28)

Country Link
US (1) US20030144506A1 (pt)
EP (1) EP1448551B1 (pt)
JP (1) JP4220388B2 (pt)
KR (1) KR20040054813A (pt)
CN (1) CN1639149A (pt)
AR (1) AR037591A1 (pt)
AT (1) ATE377009T1 (pt)
AU (1) AU2002337428A1 (pt)
BR (1) BR0214606A (pt)
CA (1) CA2462149C (pt)
DE (1) DE60223279T2 (pt)
DO (1) DOP2002000519A (pt)
ES (1) ES2295409T3 (pt)
GT (1) GT200200245A (pt)
HN (1) HN2002000334A (pt)
HU (1) HUP0500117A3 (pt)
IL (1) IL160971A0 (pt)
MX (1) MXPA04005157A (pt)
PA (1) PA8558601A1 (pt)
PE (1) PE20030643A1 (pt)
PL (1) PL370911A1 (pt)
RS (1) RS44004A (pt)
RU (1) RU2004116345A (pt)
SV (1) SV2004001419A (pt)
TN (1) TNSN02096A1 (pt)
TW (1) TW200300691A (pt)
WO (1) WO2003045939A1 (pt)
ZA (1) ZA200402054B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL377686A1 (pl) * 2002-12-18 2006-02-06 Pfizer Products Inc. Pochodne 4-anilinochinazoliny do leczenia anormalnego wzrostu komórek
KR20050085835A (ko) * 2002-12-19 2005-08-29 화이자 프로덕츠 인코포레이티드 Ｅ-2-메톡시-ｎ-（3-｛4-［3-메틸-4-（6-메틸-피리딘-3-일옥시）-페닐아미노］-퀴나졸린-6-일｝-알릴）-아세트아마이드의 착물, 및 그의 제조방법 및 용도
BRPI0409233A (pt) * 2003-04-09 2006-03-28 Pfizer Prod Inc processos para a preparação de derivados de n-((((piridinilóxi)-fenilaminoquinazolinil)-alil) acetamida e compostos relacionados, bem como intermediários de tais processos e processos para a preparação de tais intermediários
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2006074147A2 (en) 2005-01-03 2006-07-13 Myriad Genetics, Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
CA2531327A1 (en) * 2003-07-03 2005-01-13 Myriad Genetics, Inc. Compounds and therapeutical use thereof
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
AP2204A (en) * 2004-05-06 2011-02-07 Warner Lambert Co 4-phenylamino-quinazolin-6-yl-amides.
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
NZ569525A (en) * 2005-12-02 2010-09-30 Paper Products Ltd Holographic flexible tube laminate for packaging and method of making the same
BR112021005513A2 (pt) 2018-09-25 2021-06-22 Black Diamond Therapeutics, Inc. derivados de quinazolina como inibidor de tirosina quinase, composições, métodos de fabricação e uso dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW321649B (pt) * 1994-11-12 1997-12-01 Zeneca Ltd
DE19501481A1 (de) * 1995-01-19 1996-07-25 Bayer Ag 2,8-Disubstituierte Chinazolinone
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
AU2001264159A1 (en) * 2000-06-22 2002-01-02 Pfizer Products Inc. Substituted bicyclic derivatives for the treatment of abnormal cell growth

Also Published As

Publication number Publication date
CA2462149C (en) 2010-06-22
EP1448551A1 (en) 2004-08-25
CN1639149A (zh) 2005-07-13
HUP0500117A2 (hu) 2005-05-30
MXPA04005157A (es) 2004-08-11
RS44004A (en) 2006-10-27
TNSN02096A1 (en) 2005-12-23
AR037591A1 (es) 2004-11-17
IL160971A0 (en) 2004-08-31
US20030144506A1 (en) 2003-07-31
JP4220388B2 (ja) 2009-02-04
KR20040054813A (ko) 2004-06-25
TW200300691A (en) 2003-06-16
ES2295409T3 (es) 2008-04-16
ZA200402054B (en) 2005-05-23
GT200200245A (es) 2003-09-24
HUP0500117A3 (en) 2008-03-28
ATE377009T1 (de) 2007-11-15
RU2004116345A (ru) 2005-03-27
PE20030643A1 (es) 2003-07-23
JP2005515986A (ja) 2005-06-02
HN2002000334A (es) 2003-02-21
CA2462149A1 (en) 2003-06-05
EP1448551B1 (en) 2007-10-31
SV2004001419A (es) 2004-02-24
DE60223279T2 (de) 2008-05-29
AU2002337428A1 (en) 2003-06-10
DOP2002000519A (es) 2003-05-31
WO2003045939A1 (en) 2003-06-05
PA8558601A1 (es) 2003-06-30
DE60223279D1 (de) 2007-12-13
PL370911A1 (en) 2005-05-30

Similar Documents

Publication Publication Date Title
BR0111548A (pt) Derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal
BR9906013A (pt) Derivados bicìclicos heteroaromáticos úteis como agentes anticancerìgenos
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
BRPI0313942B8 (pt) derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas
BR0015911A (pt) Derivados de benzoimidazole úteis como agentes antiproliferativos
BR9709959A (pt) Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas
BRPI9913138B8 (pt) derivado de quinolin-2-ona substituído com alquinila e composição farmacêutica contendo o mesmo
BRPI0415437A (pt) composto, processo para a preparação e uso do mesmo, composição farmacêutica, processo para a preparação da mesma, e, produto
BR0008202A (pt) Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
DE60331056D1 (de) 6-11 bicyclische ketolidderivate
BR0206435A (pt) Composto, composição farmacêutica, métodos de tratar a angiogênese em um paciente, de tratar distúrbios relacionados com kdr e proliferativos em um mamìfero, uso de um composto, e, processo para preparar compostos
UA94901C2 (ru) Антибактериальные производные пиперидина
BRPI0201437B8 (pt) processos para a preparação de derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-substituídos
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
BRPI0406717A (pt) Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0010938A (pt) Derivados da 13-metil eritromicina
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
BR0214606A (pt) Processos para a preparação de derivados bicìclicos substituìdos para o tratamento de crescimento de célula anormal
BRPI0409230A (pt) formas de dosagem compreendendo ag013736
BR0317433A (pt) Derivados bicìclicos para o tratamento do crescimento celular anormal
BRPI0415546A (pt) composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, e de distúrbios

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 10A E 11A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 10A, 11A, 12A, 13A, 14A, 15A, 16A, 17A E 18A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.